Familial Alzheimer's disease associated with heterozygous NPC1 mutation

被引:0
|
作者
Lopergolo, Diego [1 ,2 ]
Bianchi, Silvia [1 ,2 ]
Gallus, Gian Nicola [1 ,2 ]
Locci, Sara [1 ,2 ]
Pucci, Barbara [1 ,3 ]
Leoni, Valerio [4 ]
Gasparini, Daniele [1 ,2 ]
Tardelli, Elisa [5 ]
Chincarini, Andrea [6 ]
Sestini, Stelvio [5 ]
Santorelli, Filippo Maria [7 ]
Zetterberg, Henrik [8 ,9 ,10 ,11 ,12 ]
De Stefano, Nicola [1 ,2 ]
Mignarri, Andrea [1 ,2 ,13 ]
机构
[1] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[2] Azienda Osped Univ Senese, UOC Neurol & Malattie Neurometab, Siena, Italy
[3] Azienda Osped Univ Senese, UOC Neurol & Neurofisiol Clin, Siena, Italy
[4] Univ Milano Bicocca, Hosp Desio, ASST Brianza, Lab Clin Chem,Sch Med & Surg, Milan, Italy
[5] Azienda USL Toscana Ctr, Dept Diagnost Imaging, Unit Nucl Med, PO S Stefano, Prato, Italy
[6] Natl Inst Nucl Phys INFN, Genoa, Italy
[7] IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Calambrone, Italy
[8] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden
[9] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[10] UCL, UK Dementia Res Inst, London, England
[11] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England
[12] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
[13] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy
基金
欧洲研究理事会; 欧盟地平线“2020”;
关键词
brain diseases; metabolic; central nervous system diseases; neurodegenerative diseases; dementia; NIEMANN-PICK-DISEASE; RAPID DIAGNOSIS; 7-KETOCHOLESTEROL; PLASMA; METABOLISM; DISORDERS; RISK;
D O I
10.1136/jmg-2023-109219
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction NPC1 mutations are responsible for Niemann-Pick disease type C (NPC), a rare autosomal recessive neurodegenerative disease. Patients harbouring heterozygous NPC1 mutations may rarely show parkinsonism or dementia. Here, we describe for the first time a large family with an apparently autosomal dominant late-onset Alzheimer's disease (AD) harbouring a novel heterozygous NPC1 mutation.Methods All the five living siblings belonging to the family were evaluated. We performed clinical evaluation, neuropsychological tests, assessment of cerebrospinal fluid markers of amyloid deposition, tau pathology and neurodegeneration (ATN), structural neuroimaging and brain amyloid-positron emission tomography. Oxysterol serum levels were also tested. A wide next-generation sequencing panel of genes associated with neurodegenerative diseases and a whole exome sequencing analysis were performed.Results We detected the novel heterozygous c.3034G>T (p.Gly1012Cys) mutation in NPC1, shared by all the siblings. No other point mutations or deletions in NPC1 or NPC2 were found. In four siblings, a diagnosis of late-onset AD was defined according to clinical characterisation and ATN biomarkers (A+, T+, N+) and serum oxysterol analysis showed increased 7-ketocholesterol and cholestane-3 beta,5 alpha,6 beta-triol.Discussion We describe a novel NPC1 heterozygous mutation harboured by different members of a family with autosomal dominant late-onset amnesic AD without NPC-associated features. A missense mutation in homozygous state in the same aminoacidic position has been previously reported in a patient with NPC with severe phenotype. The alteration of serum oxysterols in our family corroborates the pathogenic role of our NPC1 mutation. Our work, illustrating clinical and biochemical disease hallmarks associated with NPC1 heterozygosity in patients affected by AD, provides relevant insights into the pathogenetic mechanisms underlying this possible novel association.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [41] A heterozygous mutation in GOT1 is associated with familial macro-aspartate aminotransferase
    Kulecka, Maria
    Wierzbicka, Aldona
    Paziewska, Agnieszka
    Mikula, Michal
    Habior, Andrzej
    Janczyk, Wojciech
    Dabrowska, Michalina
    Karczmarski, Jakub
    Lazniewski, Michal
    Ginalski, Krzysztof
    Czlonkowska, Anna
    Socha, Piotr
    Ostrowski, Jerzy
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 1026 - 1030
  • [42] Niemann-Pick Disease Type C: Mutation Spectrum and Novel Sequence Variations in the Human NPC1 Gene
    Márcia Polese-Bonatto
    Hugo Bock
    Ana Carolina S. Farias
    Rafaella Mergener
    Maria Cristina Matte
    Mirela S. Gil
    Felipe Nepomuceno
    Fernanda T. S. Souza
    Rejane Gus
    Roberto Giugliani
    Maria Luiza Saraiva-Pereira
    Molecular Neurobiology, 2019, 56 : 6426 - 6435
  • [43] Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease
    Rita De Gasperi
    Miguel A Gama Sosa
    Stella Dracheva
    Gregory A Elder
    Molecular Neurodegeneration, 5
  • [44] Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease
    De Gasperi, Rita
    Sosa, Miguel A. Gama
    Dracheva, Stella
    Elder, Gregory A.
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [45] Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress
    Lee, Dongun
    Hong, Jeong Hee
    ANTIOXIDANTS, 2023, 12 (12)
  • [46] Niemann-Pick Disease Type C: Mutation Spectrum and Novel Sequence Variations in the Human NPC1 Gene
    Polese-Bonatto, Marcia
    Bock, Hugo
    Farias, Ana Carolina S.
    Mergener, Rafaella
    Matte, Maria Cristina
    Gil, Mirela S.
    Nepomuceno, Felipe
    Souza, Fernanda T. S.
    Gus, Rejane
    Giugliani, Roberto
    Saraiva-Pereira, Maria Luiza
    MOLECULAR NEUROBIOLOGY, 2019, 56 (09) : 6426 - 6435
  • [47] NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts
    Somerville, Emma N.
    Krohn, Lynne
    Yu, Eric
    Rudakou, Uladzislau
    Senkevich, Konstantin
    Ruskey, Jennifer A.
    Asayesh, Farnaz
    Ahmad, Jamil
    Spiegelman, Dan
    Dauvilliers, Yves
    Arnulf, Isabelle
    Hu, Michele T. M.
    Montplaisir, Jacques Y.
    Gagnon, Jean-Francois
    Desautels, Alex
    Ibrahim, Abubaker
    Stefani, Ambra
    Hoegl, Birgit
    Gigli, Gian Luigi
    Valente, Mariarosaria
    Janes, Francesco
    Bernardini, Andrea
    Dusek, Petr
    Sonka, Karel
    Kemlink, David
    Plazzi, Giuseppe
    Antelmi, Elena
    Biscarini, Francesco
    Mollenhauer, Brit
    Trenkwalder, Claudia
    Sixel-Doring, Friederike
    Figorilli, Michela
    Puligheddu, Monica
    De Cock, Valerie Cochen
    Oertel, Wolfgang
    Janzen, Annette
    Ferini-Strambi, Luigi
    Heibreder, Anna
    Monaca, Christelle Charley
    Abril, Beatriz
    Dijkstra, Femke
    Viaene, Mineke
    Boeve, Bradley F.
    Postuma, Ronald B.
    Rouleau, Guy A.
    Gan-Or, Ziv
    NEUROBIOLOGY OF AGING, 2023, 127 : 94 - 98
  • [48] Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?
    Robert P. Erickson
    Journal of Applied Genetics, 2018, 59 : 441 - 447
  • [49] Cognitive decline in patients with familial Alzheimer's disease associated with e280a presenilin-1 mutation: A longitudinal study
    Rosselli, M
    Ardila, A
    Moreno, S
    Standish, V
    Arango-Lasprilla, JC
    Tirado, V
    Ossa, J
    Goate, AM
    Kosik, KS
    Lopera, F
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2000, 22 (04) : 483 - 495
  • [50] Abnormalities in cerebral glucose metabolism of familial Alzheimer's disease associated with 670/671 APP mutation and presenilin 1 gene mutations
    Stefanova, E
    Axelman, K
    Viitanen, M
    Nordberg, A
    Nilsson, A
    Långström, B
    Andersson, J
    Lannfelt, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S479 - S479